Genomic Imprinting and Inheritance
Pedigree Analysis
Type II Diabetes I: Introduction
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Incomplete Dominance
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 20, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
A Drouet1, F Le Moigne2, D Salamé3
1Service de neurologie, HIA Desgenettes, 108, boulevard Pinel, 69275 Lyon cedex 3, France; Centre de compétence neurofibromatose, Rhône-Alpes-Auvergne, centre Léon Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France.
Neurofibromatosis type 2 (NF2) mosaicism can present with severe symptoms, not just mild forms. Early ophthalmological screening is crucial for at-risk children to ensure timely diagnosis and management of NF2.
Area of Science:
Background: